These observations led us to hypothesize that LRP5-overexpressing osteocytes inhibit breast cancer bone metastasis by engaging the LIMA1/MYO5B signaling axis, thereby disrupting tumor–stromal interactions and restoring bone–tumor homeostasis [22]. This evidence concerns the gene LRP5 and breast cancer.